Duke Cancer Institute physician-scientist Brent Hanks, MD, PhD — associate director of Translational Science for DCI’s Melanoma Disease Group and director of the Hanks Lab — has received the 2021 Conquer Cancer- Bristol-Myers Squibb Advanced Clinical Research Award in Immune Checkpoint Therapy.
This is a $450K three-year grant to further a clinical biomarker study, led by Hanks, investigating the role of the tumor NLRP3 inflammasome in immunotherapy resistance. READ MORE